Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of RPL7 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of RPL7 mRNA | decreases expression | 12852829
|
D001280 |
Atrazine |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in decreased expression of RPL7 mRNA | affects cotreatment|decreases expression | 15654877
|
D001280 |
Atrazine |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in decreased expression of RPL7 mRNA | affects cotreatment|decreases expression | 16532367
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of RPL7 mRNA | increases expression | 20498004
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of RPL7 mRNA | increases expression | 20504355
|
D002104 |
Cadmium |
Cadmium results in decreased expression of RPL7 mRNA | decreases expression | 17327700
|
D019256 |
Cadmium Chloride |
Cadmium Chloride results in decreased expression of RPL7 mRNA | decreases expression | 17327700
|
C444299 |
diindolylmethane |
diindolylmethane inhibits the reaction [Estradiol results in increased expression of RPL7 mRNA] | decreases reaction|increases expression | 11179685
|
D004237 |
Diuron |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in decreased expression of RPL7 mRNA | affects cotreatment|decreases expression | 15654877
|
D004237 |
Diuron |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in decreased expression of RPL7 mRNA | affects cotreatment|decreases expression | 16532367
|
D004958 |
Estradiol |
diindolylmethane inhibits the reaction [Estradiol results in increased expression of RPL7 mRNA] | decreases reaction|increases expression | 11179685
|
D004958 |
Estradiol |
Estradiol results in increased expression of RPL7 mRNA | increases expression | 11179685
|
D004958 |
Estradiol |
Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of RPL7 mRNA] | decreases reaction|increases expression | 11179685
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of RPL7 mRNA | decreases expression | 17557909
|
D018684 |
Glycine Agents |
Glycine Agents results in increased expression of RPL7 mRNA | increases expression | 16532367
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of RPL7 mRNA | affects cotreatment|increases expression | 17183730
|
C028904 |
isoproturon |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in decreased expression of RPL7 mRNA | affects cotreatment|decreases expression | 15654877
|
C028904 |
isoproturon |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in decreased expression of RPL7 mRNA | affects cotreatment|decreases expression | 16532367
|
D010269 |
Paraquat |
Paraquat results in increased expression of RPL7 mRNA | increases expression | 17275934
|
D012643 |
Selenium |
Selenium results in decreased expression of RPL7 mRNA | decreases expression | 19244175
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of RPL7 mRNA | increases expression | 18175754
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of RPL7 mRNA] | decreases reaction|increases expression | 11179685
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of RPL7 mRNA | affects binding|increases expression | 16214954
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of RPL7 mRNA | increases expression | 18796159
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of RPL7 mRNA | affects cotreatment|increases expression | 17183730
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of RPL7 mRNA | decreases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.11 | 11752688 14514962 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.11 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.86 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.50 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.89 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
10.02 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
10.02 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
10.02 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
10.02 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.61 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.32 | 16835633 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Atrazine |
8.72 | 11874814 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
8.72 | 11874814 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.18 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.89 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.52 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.01 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.40 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.62 | 15885639 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
3.60 | 15687053 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.01 | 20603192 18985861 18940202 18316065 18177632 17507914 19232924 15238991 18775368 18558336 19460635 17688650 18396377 16609825 17157402 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.04 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
8.75 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.75 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.73 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.88 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.88 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.79 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.79 | 17289903 16675129 17261762 19861407 14630087 12948864 17018787 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.79 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.27 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.40 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.87 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.74 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
3.00 | 16217749 11135700 14691202 15073043 15553829 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
3.00 | 16924424 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.82 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.06 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.03 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.33 | 18850075 16120746 18670907 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
6.85 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.85 | 18566989 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.68 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.10 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.82 | 17333356 17681005 17110522 16919318 11677210 16105132 15861022 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.69 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.08 | 12621046 15340226 16354765 8697196 15668235 |
MESH:D003092 |
Colitis |
|
Selenium |
3.72 | 17936198 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.12 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
5.34 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.34 | 20055451 15322242 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
5.34 | 8888407 16575769 17688650 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
5.34 | 19769572 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.03 | 15213294 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.72 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.65 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.35 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
8.83 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
8.83 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.83 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
8.83 | 19641884 1733752 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.71 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.99 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.65 | 9068938 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.32 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.85 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.12 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.94 | 19148513 18566989 11473722 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.96 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.09 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.86 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.90 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.53 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.23 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.00 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.38 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.38 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
12.77 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
12.77 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
12.77 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.39 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.83 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.07 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.89 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.20 | 16904648 |
MESH:D005911 |
Gliosis |
|
Paraquat |
5.11 | 11124998 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.54 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.90 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.90 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
10.90 | 16080930 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.03 | 17162251 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.27 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.83 | 12621046 15340226 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.68 | 16490937 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.98 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
9.86 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
9.86 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.81 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.99 | 16354765 15340226 8697196 16959395 18606429 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.88 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.56 | 16612254 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.75 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.40 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Atrazine |
11.08 | 12948887 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
11.08 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
11.08 | 4850670 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.82 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
10.77 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
10.77 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.29 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
7.29 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
14.22 | 16322080 16226777 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
14.22 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
14.22 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
14.22 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.82 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
2.92 | 15610895 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.80 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.73 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.24 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.38 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.70 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.87 | 16968895 17050201 16467208 20471514 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.87 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.17 | 11161223 12018890 15748426 17649720 16966277 12712474 19225113 19642359 15622746 16112521 16330433 17217047 12679006 19035177 16331271 17712046 17869043 15336539 16823087 16891316 15213294 9834237 11468182 17107899 19075265 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.29 | 16882451 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.41 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.41 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
3.41 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
7.23 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.23 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.23 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
5.66 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.66 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.30 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.13 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.21 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
4.77 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.77 | 18520028 18569708 17053015 20135361 18816296 6695378 20464547 20064080 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.77 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
4.77 | 11062179 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.00 | 14737004 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.88 | 11807958 11408345 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
5.88 | 15318939 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.43 | 19453300 |
MESH:D008654 |
Mesothelioma |
|
Atrazine |
6.37 | 1916698 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
6.37 | 15107826 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.14 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.14 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.06 | 15949261 19549372 14977855 11468182 19417148 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.96 | 8888407 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.62 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.29 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.29 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.96 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.23 | 16810080 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.90 | 16624393 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.14 | 11141357 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.67 | 17289903 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.66 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.25 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.25 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.18 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.18 | 16359493 8888407 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
4.76 | 12452020 19769630 16624393 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.76 | 19401270 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.50 | 15580305 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.62 | 11578682 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.10 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Atrazine |
5.61 | 17218051 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
5.61 | 16510128 15824117 11445065 11124998 15451049 16140633 11181820 12911755 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
4.37 | 16190885 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.19 | 12520081 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
5.32 | 15687053 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.83 | 15087411 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
4.39 | 12504350 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.49 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.26 | 11118676 11222880 11896295 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.26 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.82 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
1.89 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.89 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
1.89 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.89 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
1.89 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
1.89 | 15084515 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.25 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.49 | 12752131 11422049 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
2.89 | 17997886 16324872 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.84 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Atrazine |
9.68 | 11874814 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
9.68 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.77 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.82 | 16458197 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.11 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.90 | 16646077 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.06 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.69 | 17978042 1511512 15475178 3137016 14763951 11044598 11738929 16876388 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.42 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.37 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.37 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.89 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.73 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.49 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.35 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.35 | 2093021 20155912 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.47 | 16517955 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.56 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.09 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.85 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
3.04 | 19014326 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.63 | 19048282 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.90 | 15213294 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.18 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.46 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
4.96 | 12845720 20435036 11780464 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
4.96 | 17053015 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.58 | 8888407 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.23 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.54 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.48 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.19 | 15886252 |